Addition of nucleoside analogues to peg-IFNα-2a enhances virological response in chronic hepatitis B patients without early response to peg-IFNα-2a: a randomized controlled trial
Crossref DOI link: https://doi.org/10.1186/s12876-017-0657-y
Published Online: 2017-08-30
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Yan
Wang, Xu
Liu, Zhenhua
Zhou, Changyu
Qi, Wenqian
Jiao, Jian
Yu, Fan
Guo, Honghua
Zhao, Ping
Wang, Jiangbin
Funding for this research was provided by:
the Key projects of Science and Technology Agency of Jilin province (20090440)
